Registry Study to Observe Long-term Safety of Vamorolone (AGAMREE®) in Patients With Duchenne Muscular Dystrophy-SUMMIT
- Status
- RECRUITING
- Phase
- N/A
Clinical Trials Related to Catalyst Pharmaceuticals, Inc.
Related studies linked through entity extraction aliases.
Long Term Safety of Amifampridine Phosphate in Spinal Muscular Atrophy 3
- Status
- TERMINATED
- Phase
- PHASE2
Controlled Trial to Evaluate Amifampridine Phosphate in Spinal Muscular Atrophy Type 3 Patients
- Status
- COMPLETED
- Phase
- PHASE2
Long Term Safety Study of Amifampridine Phosphate in MuSK-MG (Muscle Specific Tyrosine Kinase Myasthenia Gravis)
- Status
- TERMINATED
- Phase
- PHASE3
Study to Evaluate Amifampridine Phosphate in Patients With MuSK-MG
- Status
- COMPLETED
- Phase
- PHASE3
Treatment Use of 3,4 Diaminopyridine in Congenital Myasthenia
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Phase 3 Study to Evaluate Efficacy of Amifampridine Phosphate in Lambert-Eaton Myasthenic Syndrome (LEMS)
- Status
- COMPLETED
- Phase
- PHASE3
Amifampridine Phosphate for the Treatment of Congenital Myasthenic Syndromes
- Status
- COMPLETED
- Phase
- PHASE3
Expanded Access Study Amifampridine Phosphate in Lambert-Eaton Myasthenic Syndrome (LEMS),Congenital Myasthenic Syndrome
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
A Safety, Tolerability and Pharmacokinetic Study of CPP-115
- Status
- COMPLETED
- Phase
- PHASE1
A Phase 3 Study of Amifampridine Phosphate in Patients With Lambert Eaton Myasthenic Syndrome (LEMS)
- Status
- COMPLETED
- Phase
- PHASE3
Vigabatrin for the Treatment of Cocaine Dependency
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Safety and Efficacy Study of Vigabatrin to Treat Methamphetamine Dependence
- Status
- TERMINATED
- Phase
- PHASE2
Vigabatrin for Treatment of Cocaine Dependence
- Status
- COMPLETED
- Phase
- PHASE2
Double Blind Study of Vigabatrin for the Treatment of Cocaine Dependence
- Status
- COMPLETED
- Phase
- PHASE2